The Neurogenetic Testing Market is expected to grow at a stupendous rate in the next 10 years. The healthcare industry is being driven by innovation. The very idea of “Customer is the King” is being implemented. As such, healthcare IT solutions come across as a meticulous and complex system that constitutes interconnected and large-scale systems wherein micros are being worked upon. These would be the facets of the healthcare vertical going forward.

According to the latest research by Persistence Market Research, the neurogenetic testing market is set to witness positive growth of CAGR 7% during 2021-2031. Any defect in one or more genes affecting the nervous system causes neurogenetic disorder.

These may include dementia, hereditary neuropathy, Parkinson disease, Epileptic disorders, etc. The Neurogenetic Testing market is majorly driven by advancements in DNA sequencing techniques and increasing research in the life science domain. These method provide an accurate course of treatment of the disorder.

The major drivers demand for neurogenetic testing are increasing prevalence of neurological diseases, awareness among common population about genetic screening, availability of modern diagnostic methods and increasing life science R&D. Various technological advancements are happening in DNA sequencing. Currently the method used for DNA sequencing is next-generation sequencing.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32899

Another driver is the prevalence of various neurological disorders. According to a WHO report, the European region contribute 11.2% of global burden of neurological disorder followed by Western Pacific region with 10%. According to a report, the number of deaths caused by neurological disorder is increased by 39% in the past 30 years.

This increase in the prevalence therefore acts as a driven for neurological testing market. An increase in the awareness about treatments and R & D investment by the companies for developing new techniques and acquiring other companies is expected to increase demand for neurogenetic testing during the forecast period.

COVID-19 had an impact on the neurogenetic testing market. The funds from the government increased during this time for research. But these funds were utilized for researching Sars Cov 2 genomics. This impacted the screening and many early signs of neurological disorders went undetected.

During this pandemic times, the hospitals started giving neurogenetics counselling through telephone videoconferencing (telegenetics) for remote places. However, this pandemic has allowed researchers to come up with new techniques for neurogenetic testing. The market had an overall negative impact due to COVID-19.

Request for Table of Content@ https://www.persistencemarketresearch.com/toc/32899

Some of the leading manufacturers of neurogenetic testing include,

• Neurogene Inc.
• Pacific Biosciences of California Inc.
• Victorian Clinical Genetics Services
• MedGenome
• Blueprint Genetics Oy
• Laboratory Corporation of America.

The region that is dominating the neurogenetics testing market is North America with countries like the US and Canada. These countries have increased their healthcare spending and has the presence of major players. Also, advancements in DNA sequencing techniques, increase in research funding by the government are driving factors for the market.

Followed by North America, the region that is expected to dominate the market is Asia. This is because of increase in prevalence of neurological disorders in this region. According to a report, the prevalence of neurological disorders are higher in low and middle income countries. Apart from this, the advancements in the DNA sequencing technique and an increase in life science research are driving the market.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/32899

Key Segments

By Technique

• MRI
• Next generation sequencing
• Multiplex ligation-dependent probe amplification (MLPA)
• Fragment analysis PCR

By End-user

• Hospitals
• Specialty clinics
• Research institutes
• Diagnostics laboratories

By Region

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

About Us: Persistence Market Research

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com